Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05610839 · ClinicalTrials.gov registry record · NA
A RCT of a Fully-automated Self-help AEBT Website
A NA study of AEBT Website With Check-ins and AEBT Website Without Check-ins, sponsored by Utah State University.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
- 1
- Study location
NCT05610839 is a NA study of AEBT Website With Check-ins and AEBT Website Without Check-ins that has completed, run by Utah State University. The registered enrollment target is 101 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05610839, a NA study of AEBT Website With Check-ins and AEBT Website Without Check-ins, has completed, sponsored by Utah State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
Trichotillomania (TTM) is characterized by hair pulling that is repetitive in nature leading to notable hair loss, causing clinically significant distress and resulting in impairments across social and functional domains (APA, 2013). Trichotillomania causes significant social impairment including affecting close relationships, pursuing occupational changes or advancement, or interfering with schooling (Grant et al., 2017; Woods, Flessner, Franklin, Wetterneck, et al., 2006). The core of the treatment of trichotillomania has traditionally been Habit Reversal Training (HRT) (Twohig, Bluett, et al., 2014). Another form of treatment that is gaining empirical support is Acceptance and Commitment Therapy (ACT) which has been studied in four randomized controlled trials, one studying ACT as a standalone treatment (Lee, Homan, et al., 2018), and three examining ACT combined with HRT (Twohig et al., 2021; Lee, Haeger, et al., 2018; Woods, Wetterneck, et al., 2006) which demonstrated efficacy of the combined treatment in decreasing pulling symptom severity. The prevalence of trichotillomania in the US is 1-2% of the population and yet treatment access is limited by many issues including processionals' lack of knowledge of the disorder and low treatment accessibility (Walther et al., 2010). ACT- enhanced behavior therapy has been implemented using telehealth to reach a larger population (42.2% decrease pre-to-post treatment), but telehealth still requires therapist time and incurs notable costs (Lee, Haeger, et al., 2018). The present study aims to address the gap in trichotillomania treatment accessibility by examining the role of check-ins on adherence and efficacy on afully automated, web-based ACT-enhanced HRT treatment for adults with trichotillomania across the United States. We predict that the condition with check-ins will increase adherence and efficacy of the treatment significantly more than the condition without check-ins. Additionally, we predict that hair pullin
Conditions Studied
Interventions
- BEHAVIORAL Acceptance-Enhanced Behavior Therapy
Study Locations (1)
Utah
- Utah State University - Logan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2022-11-08 |
| Est. Completion | 2023-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05610839
The ClinicalTrials.gov registry entry for NCT05610839 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Utah State University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with AEBT Website With Check-ins appearing as the primary indexed condition, and to 1 intervention - of which Acceptance-Enhanced Behavior Therapy is the first listed.
NCT05610839 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05610839 about?
NCT05610839 is a clinical study titled "A RCT of a Fully-automated Self-help AEBT Website". Trichotillomania (TTM) is characterized by hair pulling that is repetitive in nature leading to notable hair loss, causing clinically significant distress and resulting in impairments across social and functional domains (APA, 2013). Trichotillomania causes significant social impairment including af...
What is the current status of trial NCT05610839?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2022-11-08. Estimated completion is 2023-09-29.
What conditions does trial NCT05610839 study?
This clinical trial studies the following conditions: AEBT Website With Check-ins, AEBT Website Without Check-ins.
What interventions are being tested in trial NCT05610839?
The interventions under investigation include: Acceptance-Enhanced Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05610839?
This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05610839 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.